कटरीना कैफ और विकी कौशल ने बेटे को पैपराजी से मिलवाया, लेकिन साथ में रखी ये शर्त

नई दिल्ली, मई 28 -- कटरीना कैफ और विकी कौशल पिछले साल पैरेंट्स बने हैं। दोनों ने अभी तक अपने बेटे की फोटो नहीं दिखाई है। कटरीना और विकी ने फैसला किया है कि वे अपने बच्चे को पैपराजी और लाइमलाइट से दूर ... Read More

चक्रधरपुर में मनाया गया कुर्बानी का त्यौहार बकरीद

चक्रधरपुर, मई 28 -- चक्रधरपुर। कुर्बानी का त्योहार बकरीद पर गुरुवार को शहर के मस्जिदों नमाज़ अदा की गयी। इस दौरान शहर में सभी मस्जिदों में नमाज अदा किया गया। मौके पर जामा मस्जिद, लोको मस्जिद, बंगला टा... Read More

Telangana firm Coempt Edutech in focus amid CBSE-OSM row

India, May 28 -- The Central Bureau of Secondary Education (CBSE) has found itself in a mess with raining students' complain over the mismatch in their Class 12 answer sheets, produced by the board th... Read More

Speeding car rams parked lorry in Hyderabad, two hurt

Hyderabad, May 28 -- Two persons were seriously injured after a speeding car rammed into a stationary lorry parked on the roadside at NTR Nagar under the LB Nagar police station limits in Hyderabad. ... Read More

Twisha Sharma death case: Video of Giribala Singh feeding stray dog sparks outrage

New Delhi, May 28 -- Former district judge Giribala Singh was spotted outside her residence in Bhopal on Thursday morning, a day after the Jabalpur bench of the Madhya Pradesh High Court quashed her a... Read More

Baby or not, Vaibhav Sooryavanshi definitely the boss: India's one-man wrecking ball is leaving bowlers mentally scarred

India, May 28 -- We are not playing the 'What-were-you-doing-when-you-were-15-years-old' game. Vaibhav Sooryavanshi has already made that passe. What started as a thrilling novelty 12 months back has... Read More

Singapore Clinical Trial: CA088-1007: A Phase 3, Randomized, Open-Label, Multicenter Study to Compare the Efficacy and Safety of Arlocabtagene Autoleucel (BMS-986393), a GPRC5D-directed CAR-T Cell Therapy, Versus Standard Regimens in Adult Participants with Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)

Singapore, May 28 -- The Health Sciences Authority received information related to the study titled 'CA088-1007: A Phase 3, Randomized, Open-Label, Multicenter Study to Compare the Efficacy and Safety... Read More

Singapore Clinical Trial: A Multinational, Multicenter, Prospective, Randomized, Controlled, Open-Label, Phase 3 Study of Lutetium-177 (177Lu) Rosopatamab Tetraxetan in Combination with Standard of Care Versus Standard of Care Alone in Patients with Prostate-Specific Membrane Antigen (PSMA) Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC) after Androgen Receptor Pathway Inhibitor (ARPI) Treatment

Singapore, May 28 -- The Health Sciences Authority received information related to the study titled 'A Multinational, Multicenter, Prospective, Randomized, Controlled, Open-Label, Phase 3 Study of Lut... Read More

Singapore Clinical Trial: CO45042: A Phase III, Randomized, Open-Label Study Evaluating the Efficacy and Safety of Divarasib Plus Pembrolizumab Versus Pembrolizumab And Pemetrexed And Carboplatin or Cisplatin in Patients with Previously Untreated, KRAS G12C-Mutated, Advanced Or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Singapore, May 28 -- The Health Sciences Authority received information related to the study titled 'CO45042: A Phase III, Randomized, Open-Label Study Evaluating the Efficacy and Safety of Divarasib ... Read More

Singapore Clinical Trial: A Phase III, Open-label, Randomised Study of Datopotamab Deruxtecan (Dato-DXd) With or Without Durvalumab Compared with Investigator’s Choice of Chemotherapy (Paclitaxel, Nab-paclitaxel or Gemcitabine + Carboplatin) in Combination With Pembrolizumab in Patients with PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

Singapore, May 28 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Open-label, Randomised Study of Datopotamab Deruxtecan (Dato-DXd) With or Without Durv... Read More

• ««
• «
• 34
• 35
• 36
• 37
• 38
• 39
• 40
• 41
• 42
• 43
• »
• »»